1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N
(
- Contribution to journal › Article
- 2018
-
Mark
Thromboembolism in acute lymphoblastic leukemia : Results of nopho all2008 protocol treatment in patients aged 1 to 45 years
(
- Contribution to journal › Article